Clinical Trial Detail

NCT ID NCT04408924
Title Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer (CYCLONE 1)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

prostate cancer

Therapies

Abemaciclib

Age Groups: senior adult

No variant requirements are available.